295 related articles for article (PubMed ID: 32972125)
1. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.
Seo MR; Kim JW; Park EJ; Jung SM; Sung YK; Kim H; Kim G; Kim HS; Lee MS; Lee J; Hur JA; Chin BS; Eom JS; Baek HJ;
Korean J Intern Med; 2020 Nov; 35(6):1317-1332. PubMed ID: 32972125
[TBL] [Abstract][Full Text] [Related]
2. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
[TBL] [Abstract][Full Text] [Related]
3. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
[TBL] [Abstract][Full Text] [Related]
4. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
[TBL] [Abstract][Full Text] [Related]
5. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic.
Masini F; Gjeloshi K; Ferrara R; Pinotti E; Cuomo G
Rheumatol Int; 2020 Sep; 40(9):1537-1538. PubMed ID: 32666135
[No Abstract] [Full Text] [Related]
6. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.
Saldarriaga Rivera LM; Fernández Ávila D; Bautista Molano W; Jaramillo Arroyave D; Bautista Ramírez AJ; Díaz Maldonado A; Hernán Izquierdo J; Jáuregui E; Latorre Muñoz MC; Restrepo JP; Segura Charry JS
Reumatol Clin (Engl Ed); 2020; 16(6):437-446. PubMed ID: 32800760
[TBL] [Abstract][Full Text] [Related]
7. Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.
Tam LS; Tanaka Y; Handa R; Chang CC; Cheng YK; Isalm N; Li M; Lorenzo JP; Song YW; Yamamoto K; Zeng X; Haq SA
Int J Rheum Dis; 2020 Jun; 23(6):717-722. PubMed ID: 32462761
[No Abstract] [Full Text] [Related]
8. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020].
Schulze-Koops H; Iking-Konert C; Leipe J; Hoyer BF; Holle J; Moosig F; Aries P; Burmester G; Fiehn C; Krause A; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wagner U; Krüger K; Specker C; ;
Z Rheumatol; 2020 Sep; 79(7):679-685. PubMed ID: 32757030
[TBL] [Abstract][Full Text] [Related]
10. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
[TBL] [Abstract][Full Text] [Related]
12. COVID-19: a primer for the rheumatologist: management of patients and care settings.
Calabrese C; Lehman B
Curr Opin Rheumatol; 2020 Sep; 32(5):429-433. PubMed ID: 32744823
[TBL] [Abstract][Full Text] [Related]
13. How to manage rheumatic patients during the coronavirus pandemic.
Parisi S; Ditto MC; Finucci A; Fusaro E
Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
[No Abstract] [Full Text] [Related]
14. How did COVID-19 pandemic changed the Portuguese rheumatology?
Vieira-Sousa E; Fonseca JE; Santos MJ
Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820
[No Abstract] [Full Text] [Related]
15. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
Pablos JL; Abasolo L; Alvaro-Gracia JM; Blanco FJ; Blanco R; Castrejón I; Fernandez-Fernandez D; Fernandez-Gutierrez B; Galindo-Izquierdo M; Gonzalez-Gay MA; Manrique-Arija S; Mena Vázquez N; Mera Varela A; Retuerto M; Seijas-Lopez A;
Ann Rheum Dis; 2020 Sep; 79(9):1170-1173. PubMed ID: 32532753
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.
Licciardi F; Giani T; Baldini L; Favalli EG; Caporali R; Cimaz R
Pediatr Rheumatol Online J; 2020 Apr; 18(1):35. PubMed ID: 32321540
[TBL] [Abstract][Full Text] [Related]
17. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
[TBL] [Abstract][Full Text] [Related]
18. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.
Schulze-Koops H; Specker C; Iking-Konert C; Holle J; Moosig F; Krueger K
Ann Rheum Dis; 2020 Jun; 79(6):840-842. PubMed ID: 32345619
[No Abstract] [Full Text] [Related]
19. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA
Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214
[TBL] [Abstract][Full Text] [Related]
20. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
Misra DP; Agarwal V; Gasparyan AY; Zimba O
Clin Rheumatol; 2020 Jul; 39(7):2055-2062. PubMed ID: 32277367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
